Commentary

As of 31 May 2026

Market Overview

  • Global equity markets had a strong month with all key markets posting positive returns, helped by a strong reporting season. This was despite ongoing tensions in the Middle East.
  • The United States S&P 500 index rose 5.2%, the UK FTSE 100 index increased 0.3%, the Japanese Nikkei 225 gained 11.9%, the Australian ASX 200 index added 1.2% and the MSCI World index ended the month up 5.3%.
  • The S&P/NZX 50 index ended the month up 2.7%.

Fund Highlights

  • The fund ended the month up 3.9%, and ahead of the index return.
  • Infratil was in the headlines during the month, with its data centre investment, CDC, announcing a very large new contract. Infratil also sold down a portion of its Contact Energy holding, raising approximately $495 million.
  • A number of companies reported their earnings results for the period ended March during the month.
  • Overweight positions Infratil, Vista, and underweight Gentrack added value. Overweight positions EBOS, Spark and Resmed detracted value.

Performance

GoalsGetter Amova SRI Equity Fund
Open Close

Performance

at 31 May 2026
One month Three months One year Three years (p.a) Five years (p.a)
Fund performance1 3.72 -2.59 5.83 3.61 2.43
Appropriate Market Index (AMI)2 2.65 -3.32 7.37 4.67 2.24
  1. Returns are before tax and after the deduction of fees and expenses and including tax credits (if any).
  2. AMI: S&P/NZX 50 Index Gross with Imputation Credits.

    The Amova KiwiSaver Scheme SRI Equity Fund transitioned from core strategy to SRI strategy in February 2022.

5 year cumulative performance $10,000 invested

GoalsGetter KiwiSaver Scheme

Top 10 Holdings

Security Name Percentage
Fisher & Paykel Healthcare 16.33%
Infratil Limited 14.13%
Auckland International Airport Ltd 9.10%
Contact Energy Limited 7.85%
Meridian Energy Ltd NPV 6.76%
Mainfreight Limited 4.06%
Spark New Zealand Ltd 3.90%
EBOS Group Limited 3.89%
NZD BNP Paribas A/C 3.31%
Freightways Limited 3.16%